Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas
Author(s) -
Janet L. Oblinger,
Sarah S. Burns,
Elena M. Akhmametyeva,
Jie Huang,
Pan Li,
Yulin Ren,
Rulong Shen,
Beth A. MilesMarkley,
Aaron C. Moberly,
A. Douglas Kinghorn,
D. Bradley Welling,
LongSheng Chang
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now032
Subject(s) - cancer research , biology , eif4e , xiap , tumor progression , microbiology and biotechnology , apoptosis , cancer , programmed cell death , caspase , translation (biology) , biochemistry , genetics , messenger rna , gene
The eukaryotic initiation factor 4F (eIF4F) complex plays a pivotal role in protein translation initiation; however, its importance in malignant and benign Schwann cell tumors has not been explored, and whether blocking eIF4F function is effective for treating these tumors is not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom